✦ LIBER ✦

Erratum to: Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen

✍ Scribed by Chintan Parekh; Rima Jubran; Anat Erdreich-Epstein; Ashok Panigrahy; Stefan Bluml; Jonathan Finlay; Girish Dhall

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 85 KB
Volume: 103
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-010-0475-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of children with recurrent hig

Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen

✍ Chintan Parekh; Rima Jubran; Anat Erdreich-Epstein; Ashok Panigrahy; Stefan Blum 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 247 KB

Erratum to: A phase I/II trial and pharm

Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 86 KB

A phase 2 trial of single-agent bevacizu

A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas

✍ Jeffrey J. Raizer; Sean Grimm; Marc C. Chamberlain; M. Kelly Nicholas; James P. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 1 views

A phase I/II trial and pharmacokinetic s

A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 187 KB

A phase II study of the farnesyl transfe

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: A children's oncology group study

✍ Maryam Fouladi; H. Stacy Nicholson; Tianni Zhou; Fred Laningham; Kathleen J. Hel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## BACKGROUND. An open‐label Phase II study of tipifarnib was conducted to evaluate its safety and efficacy in children with recurrent or refractory medulloblastoma (MB)/primitive neuroectodermal tumor (PNET), high‐grade glioma (HGG), and diffuse intrinsic brainstem glioma (BSG). ## M

Pre-irradiation chemotherapy in children

Pre-irradiation chemotherapy in children with high-grade astrocytoma: Tumor response to two cycles of the ‘8-drugs-in-1-day’ regimen

✍ Jonathan L. Finlay; J. Russell Geyer; Patrick A. Turski; Allen J. Yates; James M 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 774 KB